Literature DB >> 18782275

Deficiency of the human complement regulatory protein factor H associated with low levels of component C9.

D A Falcão1, E S Reis, D Paixão-Cavalcante, M T Amano, M I M V Delcolli, M P C Florido, J A T Albuquerque, D Moraes-Vasconcelos, A J Duarte, A S Grumach, L Isaac.   

Abstract

We identified a 4-year-old Brazilian boy from a family of Japanese descent and history of consanguinity, who suffered from severe recurrent pneumonia. He carries factor H (FH) deficiency associated with reduced levels of component C9 and low serum levels of C3 and factor B. His mother also presented low levels of these proteins and factor I, while his father and sister had only lower levels of FH. Western blot assays confirmed the complete absence of FH and FHL-1 polypeptides in this patient. Sequencing of the proband's FH cDNA revealed a homozygous G453A substitution, encoding an Arg(127)His change. His mother, father and sister are heterozygous for this substitution. Despite the absence of FH in the plasma, this protein was detected in the patient's fibroblasts, suggesting that Arg(127) may be important for FH secretion. Low concentrations of C9 were detected in the proband serum but no mutations in the patient's C9 gene or promoter have been identified, suggesting that this is a consequence of uncontrolled complement activation and high C9 consumption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782275     DOI: 10.1111/j.1365-3083.2008.02152.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.

Authors:  Svetlana Hakobyan; Agustín Tortajada; Claire L Harris; Santiago R de Córdoba; Bryan P Morgan
Journal:  Kidney Int       Date:  2010-08-11       Impact factor: 10.612

Review 2.  Intertwined pathways of complement activation command the pathogenesis of lupus nephritis.

Authors:  Abhigyan Satyam; Ryo Hisada; Rhea Bhargava; Maria G Tsokos; George C Tsokos
Journal:  Transl Res       Date:  2022-03-14       Impact factor: 10.171

3.  The rare C9 P167S risk variant for age-related macular degeneration increases polymerization of the terminal component of the complement cascade.

Authors:  O McMahon; T M Hallam; S Patel; C L Harris; A Menny; W M Zelek; R Widjajahakim; A Java; T E Cox; N Tzoumas; D H W Steel; V G Shuttleworth; K Smith-Jackson; V Brocklebank; H Griffiths; A J Cree; J P Atkinson; A J Lotery; D Bubeck; B P Morgan; K J Marchbank; J M Seddon; D Kavanagh
Journal:  Hum Mol Genet       Date:  2021-06-17       Impact factor: 5.121

4.  Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R.

Authors:  Marcell Cserhalmi; Barbara Uzonyi; Nicolas S Merle; Dorottya Csuka; Edgar Meusburger; Karl Lhotta; Zoltán Prohászka; Mihály Józsi
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

Review 5.  The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.

Authors:  Maartje J Geerlings; Eiko K de Jong; Anneke I den Hollander
Journal:  Mol Immunol       Date:  2016-12-06       Impact factor: 4.407

Review 6.  Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.

Authors:  Laura Lorés-Motta; Eiko K de Jong; Anneke I den Hollander
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

7.  Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen.

Authors:  Rachel L Taylor; James A Poulter; Susan M Downes; Martin McKibbin; Kamron N Khan; Chris F Inglehearn; Andrew R Webster; Alison J Hardcastle; Michel Michaelides; Paul N Bishop; Simon J Clark; Graeme C Black
Journal:  Ophthalmology       Date:  2019-03-21       Impact factor: 12.079

Review 8.  Emerging Roles of Complement in Psychiatric Disorders.

Authors:  Mélanie Druart; Corentin Le Magueresse
Journal:  Front Psychiatry       Date:  2019-08-21       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.